Andre Palmer wins 2021 Gaden Award
In recognition of a "truly outstanding paper," Ohio Eminent Scholar and Professor Andre Palmer has received the 2021 Gaden Award from the journal Biotechnology & Bioengineering (Wiley).
The Gaden Award is named in honor of Elmer L. Gaden, Jr., the founding editor of Biotechnology & Bioengineering, and is given in recognition of an exceptional paper published in the Journal within the last few years.
Palmer received the honor for the following paper:
"Novel manufacturing method for producing apohemoglobin and its biophysical properties," Ivan S. Pires, Donald A. Belcher, Richard Hickey, Colbert Miller, Abraham K. Badu‐Tawiah, Jin Hyen Baek, Paul W. Buehler and Andre F. Palmer. First published: 15 October 2019 Novel
Then-graduate students Donald A. Belcher and Richard Hickey are co-authors, as is former undergraduate Ivan S. Pires, who is now pursuing a doctorate in chemical engineering at MIT. Belcher is now a postdoc at the University of Pittsburgh, and Hickey recently obtained his PhD.
Other authors include Abraham K. Badu‐Tawiah, an Ohio State professor in Chemistry, and Colbert Miller who was a graduate student in Chemistry at Ohio State at the time. Jin Hyen Baek and Paul W. Buehler were at the FDA.
The Gaden Award consists of a plaque, an honorarium of $2,000, and acknowledgement on the Journal’s website and through Wiley social media. In past years, the award was presented in person, immediately before the Gaden Award Lecture, at an ACS-BIOT Division session. This year, due to the August 2021 ACS-BIOT Annual meeting in Atlanta being held virtually, the award recipient is invited to provide a 40-minute talk at one of the virtual BIOT Awards sessions. Further details on this virtual session will be available once the meeting schedule is finalized.
___________________
About Professor Palmer
Professor Palmer is a global leader in blood substitute research and engineering biomaterials for use in transfusion medicine and tissue engineering. He is currently working to develop safer, more commercially viable red blood cell (RBC) substitutes that could tide patients over until they receive a human blood transfusion, and novel hemoglobin-based oxygen carriers for a variety of applications in transfusion medicine and tissue engineering.
His lab is also developing therapeutics for the detoxification of hemoglobin/heme/iron, non-heme based plasma substitutes, and monocyte/macrophage targeted drug delivery systems.
Palmer is the author of more than 140 peer-reviewed publications. His work is funded by grants from the National Institutes of Health and Department of Defense.
Among other honors, Palmer is a fellow of The American Institute for Medical and Biological Engineering (AIMBE), which represents the top two percent of researchers in the medical and biological engineering community in the country. He received the National Science Foundation CAREER Award, the Lloyd N. Ferguson Young Scientist Award from the National Organization for the Professional Advancement of Black Chemists and Chemical Engineers, and the Harrison Faculty Award for Excellence in Engineering Education from The Ohio State University College of Engineering.
He is a member of the Academic Advisory Board for the Department of Chemical Engineering at Howard University and chaired the William G. Lowrie Department of Chemical & Biomolecular Engineering from 2014-19.
Professor Palmer currently serves on the International Scientific Advisory Committee on Blood Substitutes, and is a member of the Bioengineering, Technology, and Surgical Sciences Study Section at the National Institutes of Health.
He obtained his PhD from The Johns Hopkins University.
